Acitretin for the treatment of hand-foot reaction associated with multikinase inhibitors

Authors

  • Federico Pastore César Milstein Institute, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v28i4.2411

Keywords:

acitretin, treatment, hand-foot reaction, multikinase inhibitors

Abstract

Multikinase inhibitors (MKIs) are used in the treatment of different cancers such as colon, kidney and thyroid cancers.

Author Biography

Federico Pastore, César Milstein Institute, Autonomous City of Buenos Aires, Argentina

Dermatologist and Legist, Dermatology Plant Physician, Dr. Enrique Tornú Hospital, Head of the Dermatology Service, César Milstein Institute

References

I. Said JT, Singer S, Lannattone L, Sauder M, et ál. Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor-Induced Hand-Foot Skin Reaction. JAMA Dermatol. 2022;158:824-826.

Published

2022-12-01

Issue

Section

Dermatological Pearls